What is TRAX return on equity (ROE)?

First Tracks Biotherapeutics reports return on equity (ROE) of -48.90% and return on assets (ROA) of -29.00%.

TRAX

First Tracks Biotherapeutics

NASDAQ: TRAX · HEALTHCARE · BIOTECHNOLOGY

$23.27

-1.57% today

Updated 2026-04-30

Market cap

$821.46M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-4.71

Dividend yield

—

52W range

$11 – $27

Volume

0.7M

Market cap

$821.46M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-4.71

Dividend yield

—

52W range

$11 – $27

Volume

0.7M

SEC filings — annual and quarterly data.

Profit margin

0.00%

Operating margin

0.00%

ROE

-48.90%

ROA

-29.00%

Debt/equity

—